Heart Valve Device Approvals: FDA Issues New Draft Guidance
This article was originally published in The Gray Sheet
Executive Summary
A single-arm clinical study with literature-based controls is typically sufficient for a PMA supporting a new open-surgery heart valve replacement device, FDA says in a draft guidance issued Jan. 20